pentoxifylline has been researched along with Primary Ovarian Insufficiency in 2 studies
Primary Ovarian Insufficiency: Cessation of ovarian function after MENARCHE but before the age of 40, without or with OVARIAN FOLLICLE depletion. It is characterized by the presence of OLIGOMENORRHEA or AMENORRHEA, elevated GONADOTROPINS, and low ESTRADIOL levels. It is a state of female HYPERGONADOTROPIC HYPOGONADISM. Etiologies include genetic defects, autoimmune processes, chemotherapy, radiation, and infections. The most commonly known genetic cause is the expansion of a CGG repeat to 55 to 199 copies in the 5' untranslated region in the X-linked FMR1 gene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboutalebi, H | 1 |
| Alipour, F | 1 |
| Ebrahimzadeh-Bideskan, A | 1 |
| Letur-Konirsch, H | 1 |
| Delanian, S | 1 |
2 other studies available for pentoxifylline and Primary Ovarian Insufficiency
| Article | Year |
|---|---|
The protective effect of co-administration of platelet-rich plasma (PRP) and pentoxifylline (PTX) on cyclophosphamide-induced premature ovarian failure in mature and immature rats.
Topics: Animals; Anti-Mullerian Hormone; Cyclophosphamide; Female; Humans; Pentoxifylline; Platelet-Rich Pla | 2022 |
Successful pregnancies after combined pentoxifylline-tocopherol treatment in women with premature ovarian failure who are resistant to hormone replacement therapy.
Topics: Adult; Drug Resistance; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; | 2003 |